# A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

> **NCT07431866** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 39 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Furosemide
- **DRUG:** MK-2828

## Key facts

- **NCT ID:** NCT07431866
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2026-06-07
- **Final completion:** 2026-06-07
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07431866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07431866, "A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07431866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*